Sharon Lu
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
- Co-authors
- Amy Rock Wohl (7 shared papers)Jong‐Hyeon Jeong (1 shared paper)Loren K. Mell (1 shared paper)Sameer K. Nath (1 shared paper)Brent S. Rose (1 shared paper)Wilbert Jordan (3 shared papers)Judith S. Currier (3 shared papers)Gildon Beall (3 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Journal of Clinical Oncology (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)British Journal of Clinical Pharmacology (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Sharon Lu
48 papers receiving 874 citations
Peers
Comparison fields: 5 of 80
- Otorhinolaryngology 92
- Oncology 304
- Infectious Diseases 139
- Obstetrics and Gynecology 43
- Epidemiology 157
Countries citing papers authored by Sharon Lu
This map shows the geographic impact of Sharon Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Lu more than expected).
Fields of papers citing papers by Sharon Lu
This network shows the impact of papers produced by Sharon Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Lu. The network helps show where Sharon Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 150 | |
| 2 | 2002 | 85 | |
| 3 | 2000 | 64 | |
| 4 | 2021 | 61 | |
| 5 | 2008 | 45 | |
| 6 | 2000 | 36 | |
| 7 | 2017 | 32 | |
| 8 | 2017 | 31 | |
| 9 | 1998 | 28 | |
| 10 | 2015 | 27 | |
| 11 | 2021 | 22 | |
| 12 | 2015 | 22 | |
| 13 | 2022 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2016 | 20 | |
| 16 | 2019 | 19 | |
| 17 | 2021 | 17 | |
| 18 | 2017 | 17 | |
| 19 | 2017 | 15 | |
| 20 | 2011 | 15 |
About Sharon Lu
Sharon Lu is a scholar working on Oncology, Surgery, Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 49 papers that have together received 927 indexed citations. Recurring topics across this work include Nausea and vomiting management (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Anesthesia and Pain Management (5 papers), HIV/AIDS Research and Interventions (4 papers), PARP inhibition in cancer therapy (4 papers), Epilepsy research and treatment (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Otorhinolaryngology (92 citations), Oncology (304 citations), Infectious Diseases (139 citations), Obstetrics and Gynecology (43 citations) and Epidemiology (157 citations). Sharon Lu has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Amy Rock Wohl, Jong‐Hyeon Jeong, Loren K. Mell, Sameer K. Nath, Brent S. Rose, Wilbert Jordan, Judith S. Currier, Gildon Beall, Denise F. Johnson and Peter R. Kerndt. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Clinical Oncology, JAIDS Journal of Acquired Immune Deficiency Syndromes, British Journal of Clinical Pharmacology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.